BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 11737787)

  • 21. [Early diagnosis and the course of Alzheimer's disease].
    Sánchez JL; Sayago AM
    Rev Neurol; 2000 Jan 16-31; 30(2):121-7. PubMed ID: 10730317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retained neuropsychological abilities of individuals with Alzheimer's disease.
    Hopper T; Bayles KA; Kim E
    Semin Speech Lang; 2001 Nov; 22(4):261-73. PubMed ID: 11574903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
    Matsuda A; Kazui H; Hirono N; Mori E
    No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global approach to multichannel electroencephalogram analysis for diagnosis and clinical evaluation in mild Alzheimer's disease.
    Yoshimura M; Isotani T; Yagyu T; Irisawa S; Yoshida T; Sugiyama M; Minami T; Sugimoto T; Nobuhara K; Okugawa G; Kinoshita T
    Neuropsychobiology; 2004; 49(3):163-6. PubMed ID: 15034231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased EEG synchronization and its correlation with symptom severity in Alzheimer's disease.
    Park YM; Che HJ; Im CH; Jung HT; Bae SM; Lee SH
    Neurosci Res; 2008 Oct; 62(2):112-7. PubMed ID: 18672010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.
    Ahmed N; Ahmed U; Thornalley PJ; Hager K; Fleischer G; Münch G
    J Neurochem; 2005 Jan; 92(2):255-63. PubMed ID: 15663474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolongation of T(2) relaxation times of hippocampus and amygdala in Alzheimer's disease.
    Wang H; Yuan H; Shu L; Xie J; Zhang D
    Neurosci Lett; 2004 Jun; 363(2):150-3. PubMed ID: 15172104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral disturbances in Alzheimer's disease: a non-pharmacological therapeutic approach.
    Silvestri A; Rosano G; Zannino G; Ricca F; Marigliano V; Fini M
    Arch Gerontol Geriatr Suppl; 2004; (9):379-86. PubMed ID: 15207436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncinate fasciculus-correlated cognition in Alzheimer's disease: a diffusion tensor imaging study by tractography.
    Morikawa M; Kiuchi K; Taoka T; Nagauchi K; Kichikawa K; Kishimoto T
    Psychogeriatrics; 2010 Mar; 10(1):15-20. PubMed ID: 20594282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
    Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
    Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.
    Laske C; Leyhe T; Stransky E; Eschweiler GW; Bueltmann A; Langer H; Stellos K; Gawaz M
    J Psychiatr Res; 2008 Jul; 42(9):746-51. PubMed ID: 17854831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Validation of the Rapid BAttery of Denomination (BARD) in 382 controls and 1004 patients of a memory clinic].
    Croisile B; Astier JL; Beaumont C; Mollion H
    Rev Neurol (Paris); 2010; 166(6-7):584-93. PubMed ID: 20226490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of brief intelligence tests for patients with Alzheimer's disease.
    Nakamura H; Nakanishi M; Furukawa TA; Hamanaka T; Tokudome S
    Psychiatry Clin Neurosci; 2000 Aug; 54(4):435-9. PubMed ID: 10997860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is confrontation naming performance in Alzheimer's disease the nominal linguistic retrogenesis of normal development?
    Kim H; Yoon JH; Lee JE; Baek EJ; Sohn YH; Na DL
    Eur Neurol; 2011; 66(4):195-9. PubMed ID: 21912136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concepts of illness in children: a comparison between children with and without intellectual disability.
    Drahota A; Malcarne VL
    Intellect Dev Disabil; 2008 Feb; 46(1):44-53. PubMed ID: 18271611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Working memory performance in children with and without intellectual disabilities.
    Henry LA; MacLean M
    Am J Ment Retard; 2002 Nov; 107(6):421-32. PubMed ID: 12323067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of Alzheimer's disease and effect on premorbid measures of intelligence.
    McFarlane J; Welch J; Rodgers J
    Br J Clin Psychol; 2006 Nov; 45(Pt 4):453-63. PubMed ID: 17076957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive performance on Piagetian tasks by Alzheimer's disease patients.
    Thornbury JM
    Res Nurs Health; 1992 Feb; 15(1):11-8. PubMed ID: 1579646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The stages of Alzheimer's disease: a reappraisal.
    Kraemer HC; Taylor JL; Tinklenberg JR; Yesavage JA
    Dement Geriatr Cogn Disord; 1998; 9(6):299-308. PubMed ID: 9769442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.